E. Levine and C. Bloomfield, Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure, Semin Oncol, vol.19, pp.47-84, 1992.

D. Milligan, R. De-elvira, M. Kolb, H. Goldstone, A. Meloni et al., Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT, British Journal of Haematology, vol.84, issue.1, pp.1020-1026, 1999.
DOI : 10.1038/sj.leu.2400795

J. Pedersen-bjergaard, P. Philip, S. Larsen, G. Jensen, and K. Byrsting, Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia, Blood, vol.76, pp.1083-91, 1990.

V. Picozzi, . Jr, G. Swanson, R. Morgan, F. Hecht et al., 13-cis retinoic acid treatment for myelodysplastic syndromes., Journal of Clinical Oncology, vol.4, issue.4, pp.589-95, 1986.
DOI : 10.1200/JCO.1986.4.4.589

K. Ballen and J. Antin, Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes, Hematol Oncol Clin North Am, vol.7, pp.477-93, 1993.

H. Kantarjian, E. Estey, and M. Keating, Treatment of therapy-related leukemia and myelodysplastic syndrome, Hematol Oncol Clin North Am, vol.7, pp.81-107, 1993.

S. Smith, L. Beau, M. Huo, D. Karrison, T. Sobecks et al., Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series, Blood, vol.102, issue.1, pp.43-52, 2003.
DOI : 10.1182/blood-2002-11-3343

C. Linassier, C. Barin, G. Calais, S. Letortorec, J. Bremond et al., Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone , cyclophosphamide, fluorouracil and radiation therapy, Annals of Oncology, vol.11, issue.10, pp.1289-94, 2000.
DOI : 10.1023/A:1008375016038

C. Kollmannsberger, J. Hartmann, L. Kanz, and C. Bokemeyer, Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies, Journal of Cancer Research and Clinical Oncology, vol.124, issue.3-4, pp.207-221, 1998.
DOI : 10.1007/s004320050156

C. Felix, Secondary leukemias induced by topoisomerase-targeted drugs, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1400, issue.1-3, pp.233-55, 1998.
DOI : 10.1016/S0167-4781(98)00139-0

J. Pedersen-bjergaard, M. Andersen, and B. Johansson, Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors., Journal of Clinical Oncology, vol.16, issue.5, pp.1897-1905, 1998.
DOI : 10.1200/JCO.1998.16.5.1897

B. Quesnel, H. Kantarjian, J. Bjergaard, P. Brault, E. Estey et al., Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature., Journal of Clinical Oncology, vol.11, issue.12, pp.2370-2379, 1993.
DOI : 10.1200/JCO.1993.11.12.2370

N. Kröger, R. Brand, A. Van-biezen, J. Cahn, S. Slavin et al., Myelodysplastic Syndromes Sub- committee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

I. Yakoub-agha, S. De-la, P. Ribaud, L. Sutton, E. Wattel et al., Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients???Report of the French Society of Bone Marrow Transplantation, Journal of Clinical Oncology, vol.18, issue.5, pp.963-71, 2000.
DOI : 10.1200/JCO.2000.18.5.963

URL : https://hal.archives-ouvertes.fr/hal-00127357

C. Chang, B. Storer, B. Scott, E. Bryant, H. Shulman et al., Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders, Blood, vol.110, issue.4, pp.1379-87, 2007.
DOI : 10.1182/blood-2007-02-076307

Z. Singh, D. Huo, J. Anastasi, S. Smith, T. Karrison et al., Therapy-Related Myelodysplastic Syndrome, American Journal of Clinical Pathology, vol.127, issue.2, pp.197-205, 2007.
DOI : 10.1309/NQ3PMV4U8YV39JWJ

P. Armand, H. Kim, D. Deangelo, V. Ho, C. Cutler et al., Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation, Biology of Blood and Marrow Transplantation, vol.13, issue.6, pp.655-64, 2007.
DOI : 10.1016/j.bbmt.2007.01.079

T. De-witte, J. Hermans, J. Vossen, A. Bacigalupo, G. Meloni et al., Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT), British Journal of Haematology, vol.67, issue.3, pp.620-650, 2000.
DOI : 10.1038/sj.bmt.1701084

K. Ballen, D. Gilliland, E. Guinan, C. Hsieh, S. Parsons et al., Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia, Bone Marrow Transplantation, vol.20, issue.9, pp.737-780, 1997.
DOI : 10.1038/sj.bmt.1700971

A. Goldstone, A. Burnett, and I. Avivi, Secondary acute myeloid leukemia has a worse outcome in MRC trials, Blood, vol.100, p.88, 2002.

C. Schoch, W. Kern, S. Schnittger, W. Hiddemann, and T. Haferlach, Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, vol.18, issue.1, pp.120-125, 2004.
DOI : 10.1038/sj.leu.2403187

W. Kern, T. Haferlach, S. Schnittger, W. Hiddemann, and C. Schoch, Prognosis in Therapy-Related Acute Myeloid Leukemia and Impact of Karyotype, Journal of Clinical Oncology, vol.22, issue.12, pp.2510-2511, 2004.
DOI : 10.1200/JCO.2004.99.301

R. Arnold, T. De-witte, A. Van-biezen, J. Hermans, N. Jacobsen et al., Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey, Bone Marrow Transplantation, vol.21, issue.12, pp.1213-1219, 1998.
DOI : 10.1038/sj.bmt.1701269

H. Castro-malaspina, R. Harris, J. Gajewski, N. Ramsay, R. Collins et al., Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program, Blood, vol.99, issue.6, pp.1943-51, 2002.
DOI : 10.1182/blood.V99.6.1943

R. Martino, S. Iacobelli, R. Brand, T. Jansen, A. Van-biezen et al., Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes, Blood, vol.108, issue.3, pp.836-882, 2006.
DOI : 10.1182/blood-2005-11-4503